-
公开(公告)号:DE3471655D1
公开(公告)日:1988-07-07
申请号:DE3471655
申请日:1984-01-16
Applicant: BASF AG
Inventor: ROSSY PHILLIP A DR , THYES MARCO DR , FRANKE ALBRECHT DR , KOENIG HORST PROF DR , LEHMANN HANS DIETER PROF DR , GRIES JOSEF DR , FRIEDRICH LUDWIG DR , LENKE DIETER PROF DR
IPC: A61K31/50 , A61K31/502 , A61K31/535 , A61K31/55 , A61P1/04 , A61P7/02 , A61P9/12 , C07D237/04 , C07D237/14 , C07D237/26 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D417/14 , C07D521/00
Abstract: Novel 6-(acylaminaryl)-3(2H)-pyridazinones of the formula (I) where R1, R2, R3, R4, A and B have the meanings given in the description, and their preparation are described. The compounds have thrombocyte aggregation-inhibiting activity.
-
公开(公告)号:CS50984A2
公开(公告)日:1987-07-16
申请号:CS50984
申请日:1984-01-23
Applicant: BASF AG
Inventor: ROSSY PHILIP A DR , THYES MARCO DR , FRANKE ALBRECHT DR , KOENIG HORST DR , LEHMANN HANS D DR , GRIES JOSEF DR , FRIEDRICH LUDWIG DR , LENKE DIETER DR
IPC: A61K31/50 , A61K31/502 , A61K31/535 , A61K31/55 , A61P1/04 , A61P7/02 , A61P9/12 , C07D237/04 , C07D237/14 , C07D237/26 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D417/14 , C07D521/00
Abstract: Novel 6-(acylaminaryl)-3(2H)-pyridazinones of the formula (I) where R1, R2, R3, R4, A and B have the meanings given in the description, and their preparation are described. The compounds have thrombocyte aggregation-inhibiting activity.
-
公开(公告)号:DE3371783D1
公开(公告)日:1987-07-02
申请号:DE3371783
申请日:1983-03-04
Applicant: BASF AG
Inventor: ROSSY PHILLIP A DR , THYES MARCO DR , FRANKE ALBRECHT DR , KOENIG HORST DR , GRIES JOSEF DR , LEHMANN HANS DIETER DR , LENKE DIETER DR
IPC: A61K31/50 , A61K31/502 , A61P7/02 , A61P9/12 , C07D237/04 , C07D237/26
Abstract: 6-Aryl-4,5-dihydro-3(2H)-pyridazinones of the formula (I) where R is hydrogen, R1 is hydrogen or C1-C3-alkyl, or R and R1 together are methylene, R2 and R3 are identical or different and are each hydrogen or C1-C6-alkyl, and A is hydroxyl, C1-C6-alkoxy, C2-C7-acyloxy, a C2-C7-carbamic acid ester group, C1-C6-alkylsulfonyloxy, C1-C6-alkylmercapto, carboxyl, C2-C7-alkoxycarbonyl or nitrile, and their preparation are described. The substances are suitable for treating disorders.
-
公开(公告)号:AT27453T
公开(公告)日:1987-06-15
申请号:AT83102127
申请日:1983-03-04
Applicant: BASF AG
Inventor: ROSSY PHILLIP A DR , THYES MARCO DR , FRANKE ALBRECHT DR , KOENIG HORST DR , GRIES JOSEF DR , LEHMANN HANS DIETER DR , LENKE DIETER DR
IPC: A61K31/50 , A61K31/502 , A61P7/02 , A61P9/12 , C07D237/04 , C07D237/26
-
公开(公告)号:DE3462136D1
公开(公告)日:1987-02-26
申请号:DE3462136
申请日:1984-11-26
Applicant: BASF AG
Inventor: FRANKE ALBRECHT DR , SPIEGLER WOLFGANG DR , SIEGEL HARDO DR , MUELLER CLAUS D DR , VON PHILIPSBORN GERDA DR , LENKE DIETER PROF DR , GRIES JOSEF DR
IPC: A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/495 , A61P9/06 , C07D207/32 , C07D207/333 , C07D213/50 , C07D231/12 , C07D307/46 , C07D333/22 , C07D409/12
-
公开(公告)号:AT17571T
公开(公告)日:1986-02-15
申请号:AT84102634
申请日:1984-03-10
Applicant: BASF AG
Inventor: FRANKE ALBRECHT DR , GRIES JOSEF DR , MUELLER CLAUS D DR , LENKE DIETER PROF DR
IPC: C07D211/52 , A61K31/13 , A61K31/445 , A61K31/451 , A61P9/06 , C07C67/00 , C07C213/00 , C07C217/32 , C07C313/00 , C07C323/25 , C07D211/44 , C07D295/08 , C07D295/092 , C07D303/22 , C07C93/06
-
57.
公开(公告)号:DE3172852D1
公开(公告)日:1985-12-12
申请号:DE3172852
申请日:1981-12-23
Applicant: BASF AG
Inventor: FRANKE ALBRECHT DR , STEINER GERD DR , THIEME PETER C DR , LENKE DIETER DR , GRIES JOSEF DR , TESCHENDORF HANS-JUERGEN DR
IPC: C07D249/08 , A61K31/41 , A61K31/415 , A61K31/42 , A61K31/495 , A61K31/496 , A61K31/505 , A61P9/02 , A61P11/08 , A61P25/08 , A61P25/20 , C07D231/12 , C07D231/38 , C07D233/60 , C07D233/88 , C07D239/42 , C07D261/08 , C07D295/06 , C07D295/092 , C07D521/00
Abstract: Novel (hetarylphenoxy)-(phenylpiperazinyl)-propanols of the formula I where R1 is hydrogen, amino or alkyl of 1 to 4 carbon atoms, R2 is hydrogen, halogen, alkyl of 1 to 4 carbon atoms or alkoxy where alkyl is of 1 to 3 carbon atoms, the phenyl ring can be monosubstituted or disubstituted by R2, and the heterocyclic structure Het. is pyrimidinyl, triazol-1-yl, imidazol-1-yl, pyrazol-3-yl or isoxazol-3-yl, and their physiologically tolerated addition salts with acids, processes for their preparation, and pharmaceutical formulations which contain these compounds and exhibit predominantly hypotensive, sedative, neuroleptic and broncholytic properties.
-
58.
公开(公告)号:AT16180T
公开(公告)日:1985-11-15
申请号:AT83111353
申请日:1983-11-14
Applicant: BASF AG
Inventor: KUBINYI HUGO DR , TRAUT MARTIN DR , GRIES JOSEF DR
IPC: A61K31/455 , A61K31/185 , A61K38/00 , A61P9/12 , A61P25/04 , C07C67/00 , C07C325/00 , C07C327/20 , C07C327/32 , C07D205/04 , C07D207/16 , C07D209/20 , C07D209/26 , C07D211/60 , C07D217/26 , C07D277/06 , C07D333/24 , C07K5/062 , C07K5/065 , C07K5/078 , C07C153/07
-
59.
公开(公告)号:AT12099T
公开(公告)日:1985-03-15
申请号:AT82102699
申请日:1982-03-31
Applicant: BASF AG
Inventor: EHRMANN OSKAR DR , RASCHACK MANFRED DR , GRIES JOSEF DR , KRETZSCHMAR ROLF DR , LEHMANN HANS DIETER DR , FRIEDRICH LUDWIG DR , WUPPERMANN DIRK DR , ZIMMERMANN FRANK DR , SEITZ WERNER DR , TREIBER HANS JOERG DR , DENGEL FERDINAND DR , FRANK WOLFRAM DR , KURBJUWEIT HANS-GEORG DR , MUELLER CLAUS D DR
IPC: A61K31/275 , A61K31/335 , C07D317/60 , C07D319/08 , C07C121/75 , C07C121/66 , C07C149/42
-
公开(公告)号:GR81690B
公开(公告)日:1984-12-12
申请号:GR830173392
申请日:1983-12-29
Applicant: BASF AG
Inventor: ROSSY PHILLIP A DR , THYES MARCO DR , FRANKE ALBRECHT DR , KOENIG HORST DR , LEHMANN HANS DIETER DR , GRIES JOSEF DR , FRIEDRICH LUDWIG DR , LENKE DIETER DR
IPC: A61K31/50 , A61K31/502 , A61K31/535 , A61K31/55 , A61P1/04 , A61P7/02 , A61P9/12 , C07D237/04 , C07D237/14 , C07D237/26 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D417/14 , C07D521/00
Abstract: Novel 6-(acylaminaryl)-3(2H)-pyridazinones of the formula (I) where R1, R2, R3, R4, A and B have the meanings given in the description, and their preparation are described. The compounds have thrombocyte aggregation-inhibiting activity.
-
-
-
-
-
-
-
-
-